Susquehanna International Group’s Fulcrum Therapeutics FULC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $684K | Buy |
99,490
+34,650
| +53% | +$238K | ﹤0.01% | 3868 |
|
|
2025
Q1 | $187K | Buy |
64,840
+24,063
| +59% | +$69.3K | ﹤0.01% | 5557 |
|
|
2024
Q4 | $192K | Buy |
40,777
+4,206
| +12% | +$19.8K | ﹤0.01% | 5341 |
|
|
2024
Q3 | $131K | Sell |
36,571
-45,024
| -55% | -$161K | ﹤0.01% | 5019 |
|
|
2024
Q2 | $506K | Sell |
81,595
-479,397
| -85% | -$2.97M | ﹤0.01% | 3508 |
|
|
2024
Q1 | $5.3M | Sell |
560,992
-105,601
| -16% | -$997K | ﹤0.01% | 992 |
|
|
2023
Q4 | $4.5M | Buy |
666,593
+161,252
| +32% | +$1.09M | ﹤0.01% | 1221 |
|
|
2023
Q3 | $2.24M | Buy |
505,341
+258,113
| +104% | +$1.15M | ﹤0.01% | 1730 |
|
|
2023
Q2 | $816K | Buy |
247,228
+188,161
| +319% | +$621K | ﹤0.01% | 2979 |
|
|
2023
Q1 | $168K | Buy |
+59,067
| New | +$168K | ﹤0.01% | 4980 |
|
|
2022
Q4 | – | Sell |
-10,006
| Closed | -$81K | – | 6168 |
|
|
2022
Q3 | $81K | Sell |
10,006
-7,681
| -43% | -$62.2K | ﹤0.01% | 5354 |
|
|
2022
Q2 | $87K | Buy |
+17,687
| New | +$87K | ﹤0.01% | 5057 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6021 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 6026 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 5582 |
|
|
2021
Q2 | – | Sell |
-31,594
| Closed | -$372K | – | 5526 |
|
|
2021
Q1 | $372K | Buy |
+31,594
| New | +$372K | ﹤0.01% | 4143 |
|
|
2019
Q4 | – | Sell |
-13,397
| Closed | -$89K | – | 4274 |
|
|
2019
Q3 | $89K | Buy |
+13,397
| New | +$89K | ﹤0.01% | 4103 |
|